Loading company…
Synaptic Pharmaceutical discovers and develops drugs using a G-protein coupled receptor platform.
Based in Paramus, New Jersey, Synaptic Pharmaceutical Corporation uses a G-protein coupled receptor (GPCR) platform to develop therapeutic products.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in